Glad to share new findings on behalf of REMOVE Trial Investigators
✅ Best oral presentation at EACTS 2023 (🎙️@HrisKirov)
✅ EJCTS Publication
‼️Hemoadsorption use in patients with S.aureus IE was not associated with ⬇️ organ dysfunction or mortality
🔗https://t.co/J8x6nHh1fQ
🆕Check out our new study published in @JAHA_AHA
‼️Patients with IE and formal indication for surgical intervention who underwent surgery are associated with a lower risk of short- and long-term mortality when compared with conservative treatment.
🔗See: https://t.co/Diyf0PSHum
@luca_koechlin@HrisKirov@ToDoenst@TulioCaldonazo @PCSchulzeMD @alexmoschovasmd@FaerberGloria Thank you Dr. Köchin for the question. The REMOVE study was conducted in 14 cardia surgery Centers. Measurements of high sensitivity Troponin was done according to the available Troponin assays in each Centers. Therefore, either Troponin I or T was used.
Results of this #JACCAdvances meta-analysis suggest antithrombotic therapy in infective endocarditis patients was not associated with a higher frequency of cerebrovascular events or intracranial hemorrhage. Learn more: https://t.co/oN7ejAYrzS
Outcomes of Concomitant Coronary Artery Bypass Grafting in Patients With Infective Endocarditis: A Systematic Review and Meta-Analysis - ScienceDirect https://t.co/pIXokpRrvT
Does the Use of Anticoagulation or Antiplatelet
Therapy Increase Cerebrovascular Events in Patients with Infective Endocarditis? Presented by @MahmDiab#ESC2023@ODzemali (chairperson)
Find a summary ⬇️
➡️ In endocarditis patients, adding CABG to valve surgery do not affect perioperative or long-term mortality. Additionally, concomitant CABG may be associated with higher postoperative stroke.
#STSCoronaryConf2023@MahmDiab@ToDoenst@HrisKirov
🔥Hot off the press🔥
We summarized all available evidence on the cardiac surgery field provided in 2022.
Check out the new contributions about the treatment of coronary artery disease, aortic surgery, valve disease and terminal HF.
See more: https://t.co/nLJgDqGG9m
@LBaddour1@MayoClinicINFD@MayoClinicCVS Thank you for the comment. We did subgroups-analyses including S. aureus IE as a subgroup compared to non-S. aureus IE. There was also no difference between hemoadsorption group and the control group.